Jed Kaminetsky

2.5k total citations
66 papers, 1.7k citations indexed

About

Jed Kaminetsky is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Urology. According to data from OpenAlex, Jed Kaminetsky has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Psychiatry and Mental health and 25 papers in Urology. Recurrent topics in Jed Kaminetsky's work include Hormonal and reproductive studies (39 papers), Sexual function and dysfunction studies (26 papers) and Urinary Bladder and Prostate Research (24 papers). Jed Kaminetsky is often cited by papers focused on Hormonal and reproductive studies (39 papers), Sexual function and dysfunction studies (26 papers) and Urinary Bladder and Prostate Research (24 papers). Jed Kaminetsky collaborates with scholars based in United States, Italy and Canada. Jed Kaminetsky's co-authors include Claus G. Roehrborn, Kevin T. McVary, Marc Gittelman, Stephen M. Auerbach, Anne Esler, Barton Wachs, Gregory D. Sides, Jay M. Young, Béla Dénes and Neal D. Shore and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and The Journal of Urology.

In The Last Decade

Jed Kaminetsky

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jed Kaminetsky United States	20	1.0k	742	613	449	430	66	1.7k
Jae Seog Hyun South Korea	19	360 0.4×	356 0.5×	513 0.8×	118 0.3×	121 0.3×	68	975
Aksam Yassin Germany	33	385 0.4×	2.3k 3.1×	1.0k 1.6×	237 0.5×	48 0.1×	100	2.9k
Nam Cheol Park South Korea	19	344 0.3×	478 0.6×	637 1.0×	47 0.1×	82 0.2×	67	1.1k
Andersson Ke Sweden	20	343 0.3×	164 0.2×	151 0.2×	117 0.3×	207 0.5×	48	1.1k
Roberto Bruzziches Italy	21	184 0.2×	921 1.2×	669 1.1×	31 0.1×	62 0.1×	33	1.3k
Jörg Schnitker Germany	16	202 0.2×	272 0.4×	161 0.3×	48 0.1×	101 0.2×	30	882
Geoff Hackett United Kingdom	16	139 0.1×	713 1.0×	630 1.0×	31 0.1×	28 0.1×	39	1.0k
Franca Fruzzetti Italy	29	102 0.1×	702 0.9×	91 0.1×	49 0.1×	48 0.1×	106	2.2k
Tomoya Kataoka Japan	13	95 0.1×	250 0.3×	244 0.4×	35 0.1×	31 0.1×	59	527
Neil F. Goodman United Kingdom	12	57 0.1×	535 0.7×	114 0.2×	23 0.1×	34 0.1×	20	1.3k

Countries citing papers authored by Jed Kaminetsky

Since Specialization

Citations

This map shows the geographic impact of Jed Kaminetsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jed Kaminetsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jed Kaminetsky more than expected).

Fields of papers citing papers by Jed Kaminetsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jed Kaminetsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jed Kaminetsky. The network helps show where Jed Kaminetsky may publish in the future.

Co-authorship network of co-authors of Jed Kaminetsky

This figure shows the co-authorship network connecting the top 25 collaborators of Jed Kaminetsky. A scholar is included among the top collaborators of Jed Kaminetsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jed Kaminetsky. Jed Kaminetsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maruzzo, Marco, Osvaldo Padron, María J. Ribal, et al.. (2025). A PHASE 1 DOSE-ESCALATION STUDY OF UGN-301 (ZALIFRELIMAB) IN PATIENTS WITH RECURRENT NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC). Urologic Oncology Seminars and Original Investigations. 43(3). 54–54.

Efros, Mitchell, et al.. (2024). Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy. Endocrine Practice. 30(9). 847–853.

Elterman, Dean, Mark N. Alshak, Neal D. Shore, et al.. (2022). An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device. Journal of Endourology. 37(1). 74–79. 8 indexed citations

Vangara, Kiran Kumar, Benjamin Bruno, Nachiappan Chidambaram, et al.. (2021). Efficacy and Safety of TLANDO, A Novel Oral Easy to Prescribe and Use TRT Option. Journal of the Endocrine Society. 5(Supplement_1). A486–A486. 2 indexed citations

Swerdloff, Ronald S., Christina Wang, William B. White, et al.. (2020). A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism. 105(8). 2515–2531. 61 indexed citations

Chidambaram, Nachiappan, Benjamin Bruno, Mahesh Patel, et al.. (2020). MP45-15 A NOVEL ORAL TESTOSTERONE THERAPY RESTORES TESTOSTERONE TO EUGONADAL LEVELS WITHOUT DOSE TITRATION. The Journal of Urology. 203(Supplement 4). 2 indexed citations

Shore, Neal D., Ronald Tutrone, Mitchell Efros, et al.. (2018). Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement. World Journal of Urology. 36(5). 801–809. 13 indexed citations

Kaminetsky, Jed, et al.. (2018). Patient perspectives on Peyronie’s disease: results of poststudy interviews from a phase 2 trial of collagenase clostridium histolyticum. International Journal of Impotence Research. 31(4). 263–268. 6 indexed citations

Sussman, David, Jed Kaminetsky, Mitchell Efros, et al.. (2017). PD26-03 SER120 NASAL SPRAY IS EFFECTIVE IN PATIENTS WITH NOCTURIA IRRESPECTIVE OF ETIOLOGY: A POOLED ANALYSIS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIALS. The Journal of Urology. 197(4S). 1 indexed citations

10.

Stock, Richard G., David Beyer, Jed Kaminetsky, & William Ge. (2017). Performance of a palladium-103 line source for prostate brachytherapy implants: A Phase I trial. Brachytherapy. 16(5). 1007–1012. 3 indexed citations

11.

Roehrborn, Claus G., Steven Gange, Marc Gittelman, et al.. (2016). Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. The Journal of Urology. 197(6). 1507–1516. 89 indexed citations

12.

Levine, Laurence A., Martin K. Gelbard, James P. Tursi, et al.. (2015). PD48-06 OUTCOMES ASSOCIATED WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE'S DISEASE BY DURATION OF DISEASE. The Journal of Urology. 193(4S). 1 indexed citations

13.

Pinggera, Germar‐Michael, Ferdinand Frauscher, Darius A. Paduch, et al.. (2014). Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial. Urology. 84(2). 412–420. 18 indexed citations

14.

Kaminetsky, Jed, et al.. (2013). Oral Enclomiphene Citrate Stimulates the Endogenous Production of Testosterone and Sperm Counts in Men with Low Testosterone: Comparison with Testosterone Gel. The Journal of Sexual Medicine. 10(6). 1628–1635. 56 indexed citations

15.

Kaminetsky, Jed, et al.. (2011). A Phase IV Prospective Evaluation of the Safety and Efficacy of Extended Release Testosterone Pellets for the Treatment of Male Hypogonadism. The Journal of Sexual Medicine. 8(4). 1186–1196. 27 indexed citations

16.

Mulhall, John P., Jed Kaminetsky, Stanley E. Althof, et al.. (2011). Correlations With Satisfaction Measures in Men Treated With Phosphodiesterase Inhibitors for Erectile Dysfunction. American Journal of Men s Health. 5(3). 261–271. 5 indexed citations

17.

Ströberg, Peter, et al.. (2010). Hardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100-mg fixed-dose or flexible-dose sildenafil citrate. International Journal of Impotence Research. 22(4). 284–289. 8 indexed citations

18.

Dmochowski, Roger R., et al.. (2009). 471 URODYNAMIC EFFECTS OF TADALAFIL 20 MG ONCE DAILY VERSUS PLACEBO IN MEN WITH SIGNS AND SYMPTOMS OF BENIGN PROSTATIC HYPERPLASIA. European Urology Supplements. 8(4). 238–238. 1 indexed citations

19.

McVary, Kevin T., Claus G. Roehrborn, Jed Kaminetsky, et al.. (2007). Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. The Journal of Urology. 177(4). 1401–1407. 286 indexed citations

20.

Steidle, Christopher P., et al.. (2006). Early sildenafil dose optimization and personalized instruction improves the frequency, flexibility, and success of sexual intercourse in men with erectile dysfunction. International Journal of Impotence Research. 19(2). 154–160. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact